Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 33

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

394

WORD

345

HTML

3844

Figures (1-8)

193

Sum=4776

Publishing Process of This Article

Item

Count

Browse

1017

Download

445

Sum=1462

Sep 7, 2014 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Sep 7, 2014; 20(33): 11753-11761
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11753

Full Size Figure Download Figure

Figure 1 Changes in body weight of control, non-alcoholic fatty liver disease and osthol groups. NAFLD: Non-alcoholic fatty liver disease.

Citation: Nam HH, Jun DW, Jeon HJ, Lee JS, Saeed WK, Kim EK. Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance. World J Gastroenterol 2014; 20(33): 11753-11761
URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11753.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11753